Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Sales | 52,283 | 49,697 | 50,140 | 54,125 | 46,809 |
| Cost of Goods | 20,273 | 19,067 | 18,994 | 20,648 | 17,770 |
| Gross Profit | 32,010 | 30,630 | 31,146 | 33,477 | 29,039 |
| Operating Expenses | 24,222 | 21,890 | 27,836 | 19,939 | 19,724 |
| Operating Income | 8,061 | 8,807 | 4,304 | 14,186 | 10,085 |
| Interest Expense | 395 | 404 | 407 | 408 | 423 |
| Other Income | -8 | 231 | 49 | 412 | -3 |
| Pre-tax Income | 7,658 | 8,634 | 3,946 | 14,190 | 9,659 |
| Income Tax | 1,356 | 2,908 | 3,706 | 4,878 | 3,380 |
| Net Income Continuous | 6,302 | 5,726 | 240 | 9,312 | 6,279 |
| Net Income | $6,302 | $5,726 | $240 | $9,312 | $6,279 |
| EPS Basic Total Ops | 0.15 | 0.13 | 0.01 | 0.22 | 0.15 |
| EPS Basic Continuous Ops | 0.15 | 0.14 | 0.01 | 0.22 | 0.15 |
| EPS Diluted Total Ops | 0.15 | 0.13 | 0.01 | 0.22 | 0.15 |
| EPS Diluted Continuous Ops | 0.15 | 0.13 | 0.01 | 0.22 | 0.15 |
| EBITDA(a) | $10,346 | $11,054 | $13,217 | $16,441 | $12,388 |